PROGRAM
 







SCIENTIFIC PROGRAM
> Program > Scientific Program


Basic Research
  
Basic 01: Rotor or Reentry 12 October 13:30-15:00 RM 12
(E 6)
Chair
Minglong CHEN (The First Affiliated Hospital Of Nanjing Medical University, China)
Hui-Nam PAK (Yonsei University Health System, Republic of Korea)
Edward P. GERSTENFELD (University of California, United States)
Speaker
Quantification of Rotor Activity and Focal Activation During Human Atrial Fibrillation
Maurits ALLESSIE (Maastricht University, Netherlands)
Rotor in AF - Fact and Fiction
Shih-Ann CHEN (Taipei Veteran General Hospital / National Yang Ming University, Taiwan)
High Resolution Mapping of Rotors: Optical vs. Electrical Mapping
Igor EFIMOV (George Washington University, United States)
Chamber Specific Macromolecular Ion Channel Complexes in the Control of Cardiac Excitability and Arrhythmogenesis
José JALIFE (University of Michigan, United States)

Basic Research
  
Basic 02: New Mechanism of Arrhythmia - Updates (I) 12 October 15:30-17:00 RM 12
(E 6)
Chair
Yukiomi TSUJI (Nagasaki University Graduate School of Biomedical Sciences, Japan)
Yu-Cheng HSIEH (Taichung Veterans General Hospital and Chiayi Branch, Taiwan)
Young Soo LEE (Daegu Catholic University Medical Center, Republic of Korea)
Speaker
Role of Acetylcholine Dependent Potassium Current in AF Maintenance
Tae-Joon CHA (Kosin University Gospel Hospital, Republic of Korea)
Atrial Innervation Pattern of GP
Seil OH (Seoul National University Hospital, Republic of Korea)
Ankyrin B Syndrome in Japanese Patients with Inherited Primary Arrhythmia Syndromes
Minoru HORIE (Shiga University of Medical Science, Japan)
Gap Junction and Susceptibility in Ventricular Arrhythmia
Yu-Cheng HSIEH (Taichung Veterans General Hospital and Chiayi Branch, Taiwan)

CIED
  
Device 01: Pacing in Special Patient Populations
 12 October 13:30-15:00 RM 02
(GBR 101)
Chair
Mohammad KHALILULLAH (The Heart Centre, Delhi, India)
Johannes BRACHMANN (Klinikum Coburg GmbH, Germany)
Neil STRATHMORE (Royal Melbourne Hospital, Australia)
Speaker
Patients with Chronic Kidney Disease/ ESRD
Joseph MORTON (The Royal Melbourne Hospital, Australia)
Patients Older than Ninety Years
Ta-Chuan TUAN (Taipei Veterans General Hospital, Taiwan)
Patients after TAVI
Sang-Weon PARK (Sejong General Hospital, Republic of Korea)
Patients with Cardiac Sarcoidosis
Anil SAXENA (Fortis Escorts Heart Institute, India)

CIED
  
Device 02: Primary Prevention ICDs in Special Populations 12 October 15:30-17:00 RM 02
(GBR 101)
Chair
Win-Kuang SHEN (Mayo Clinic, United States)
David HAYES (Mayo Clinic, United States)
Yoshifusa AIZAWA (TACHIKAWA Medical Center, Japan)
Speaker
Primary Prevention in Patients with Brugada Syndrome and Early Repolarization Syndrome
Itsuro MORISHIMA (Ogaki Municipal Hospital, Japan)
ICD Therapy in Patients with Vasospastic Angina
Ki Hong LEE (Chonnam National University Hospital, Republic of Korea)
Primary Prevention ICD in Hypertrophic Cardiomyopathy
Eiichi WATANABE (Fujita Health University School of Medicine, Japan)
Primary Prevention ICD in ARVC/D
Ajay NAIK (CIMS Hospital, India)
Discontinuance of CIED Therapy: Recurrent Shocks, Operations and End of Life
Paul GOULD (Princess Alexandra Hospital, Australia)

Clinical EP
  
AF 01: Anatomical Information for AF Ablation 12 October 13:30-15:00 RM 01
(Auditorium)
Chair
Norishige MORITA (Tokai University Hachioji Hospital, Japan)
Christopher X. WONG (University of Adelaide and Royal Adelaide Hospital, Australia)
Yi-Jen CHEN (Taipei Medical University, Taiwan)
Speaker
The Architecture of the Left Atrial Wall
Jeong-Wook SEO (Seoul National University Hospital, Republic of Korea)
Anatomical Consideration for Transseptal Catheterization
Roberto DE PONTI (University of Insubria-Varese, Italy)
Anatomic Determinants for Ablation of Atrial Fibrillation
José Ángel Cabrera RODRÍGUEZ (Hospital Universitario Quiron Madrid, Spain)
Anatomy for the AT Mapping and Ablation
Hsuan-Ming TSAO (National Yang Ming Univeristy Hospital, Taiwan)

Clinical EP
  
AF 02: Ablation of Persistent AF: Substrate Modification 12 October 15:30-17:00 RM 01
(Auditorium)
Chair
Kiyoshi OTOMO (Nishinomiya Watanabe Cardiovascular Center, Japan)
Stuart THOMAS (Westmead Hospital, Australia)
Koichiro KUMAGAI (Fukuoka Sanno Hospital, Japan)
Speaker
EHRA/ HRS/ APHRS Consensus Paper on Atrial Cardiomyopathies
Andreas GOETTE (St. Vincenz-Hospital, Germany)
Role of Pharmacologic Therapy in AF
Alexander BURASHNIKOV (Lankenau Institute for Medical Research, United States)
Strategies for Ablation of Persistent AF
Oussama WAZNI (Cleveland Clinic, United States)
Epicardial Adipose Tissue Ablation in Persistent AF
Koji KUMAGAI (Gunma Prefectural Cardiovascular Center, Japan)
Catheter Ablation for Long-standing Persistent Atrial Fibrillation: Potential Driving Mechanism and Optimal Ablation Strategy
Yoshito IESAKA (Tsuchiura Kyodo General Hospital, Japan)

Clinical EP/SVT
  
SVT 01: Case Based Tutorial 12 October 13:30-15:00 RM 05
(GBR 104)
Chair
Teiichi YAMANE (Jikei University School of Medicine, Japan)
Kwok-Keung CHAN (Pamela Youde Nethersole Eastern Hospital, Hong Kong)
Chun-Chieh WANG (Chang Gung Memorial Hospital & Chang Gung University, Taiwan)
Speaker
Challenging SVT Ablation Cases
Ju-Youn KIM (The Catholic University of Korea, Seoul St. Mary's Hospital, Republic of Korea)
Challenging SVT Ablation Cases
Cathy LAM (Private Practice, Hong Kong)
Challenging SVT Ablation Cases
Kelvin WONG (Changi General Hospital, Singapore)
Challenging SVT Ablation Cases
Narayanan NAMBOODIRI (Sree Chitra Tirunal Institute for Medical Sciences and Technologhy (SCTIMST), India)

Clinical EP/SVT
  
SVT 02: Debate: When the Entrainment and 3D Mapping of AT Conflicts in the Era of High Density 3D Mapping 12 October 15:30-17:00 RM 05
(GBR 104)
Chair
Hiroshi TADA (University of Fukui, Japan)
Yenn-Jiang LIN (Taipei Veterans General Hospital, Taiwan)
Speaker
Ablation Should Be Guided by Entrainment Mapping
Jaemin SHIM (Korea University Anam Hospital, Republic of Korea)
I Do Depend on Entrainment Mapping
Peter KISTLER (Alfred Hospital and Baker Heart and Diabetes Institute, Australia)
Ablation Should Be Guided by 3D Mapping
Gi-Byoung NAM (ASAN Medical Center, Republic of Korea)
I Do Depend on 3D Mapping
Hiroshi NAKAGAWA (University of Oklahoma Health Sciences Center, United States)
A Balanced View on the Activation and Entrainment Mapping
Samuel ASIRVATHAM (Mayo Clinic, United States)

Clinical EP/VT
  
VT 01: Ventricular Ectopy – Predictors of PVC Induced Cardiomyopathy 12 October 13:30-15:00 RM 06
(GBR 105)
Chair
Akihiko NOGAMI (University of Tsukuba, Japan)
Ajit THACHIL (Lisie Hospital, India)
Kejiang CAO (Jiangsu Province Hospital, China)
Speaker
Risk Stratification of VPC from Holter Monitoring
Erika MAHARANI (Sardjito Hospital, YOGYAKARTA, Indonesia)
Can PVC QRS Duration Be a New Marker for the Development of Premature Ventricular Contraction-induced Cardiomyopathy?
Yukio SEKIGUCHI (University of Tsukuba, Japan)
Early Detection of Subtle Electromechanical Dysfunction in Patients with Idiopathic PVC
Shih-Lin CHANG (Taipei Veterans General Hospital, Taiwan)
Mechanisms of LV Dysfunction Both Systolic and Diastolic Caused by Premature Ventricular Complexes
Venkat THOLAKANAHALLI (University of Minnesota, United States)

Clinical EP/VT
  
VT 02: New Treatment for VT/VF 12 October 15:30-17:00 RM 06
(GBR 105)
Chair
In Suck CHOI (Gachon University Gill Medical Center, Republic of Korea)
Satoshi HIGA (Makiminato Central Hospital, Japan)
Tsu-Juey WU (Taichung Veterans General Hospital, Taiwan)
Speaker
Contemporary Approaches to Ablation of Intramural VT
David J. WILBER (Loyola University Medical Center, United States)
New Technologies for VT Ablation
Edward P. GERSTENFELD (University of California, United States)
Percutaneous Left Ventricular Assist Devices in Ventricular Tachycardia Ablation
Kalyanam SHIVKUMAR (UCLA Health System, United States)
Treatment of Recurrent VT After Surgery for Refractory VT
Yasushi MIYAUCHI (Nippon Medical School Chiba-Hokuso Hospital, Japan)

SCD
  
SCD 01: Challenges in Asymptomatic Long QT Syndrome 12 October 13:30-15:00 RM 03
(GBR 102)
Chair
Priya CHOCKALINGAM (Cardiac Wellness Institute, India)
Gyo-Seung HWANG (Ajou University Medical Center, Republic of Korea)
Michael J. ACKERMAN (Mayo Clinic, United States)
Speaker
How to Stratify the Risk in Asymptomatic Borderline QT Patients?
Santokh S. DHILLON (Dalhousie University, Canada)
Unmasking Long QT Syndrome
Ajay NAIK (CIMS Hospital, India)
Updated Diagnostic Criteria for Long QT Syndrome
Kenshi HAYASHI (Kanazawa University Graduate School of Medical Science, Japan)
New Development in LQTs and Its Mechanism of Drug Therapy
Dao W WANG (Nanjing Medical University THe First Affiliated Hospital, China)

SCD
  
SCD 02: Long QT Syndrome: Phenotype and Genotype 12 October 15:30-17:00 RM 03
(GBR 102)
Chair
Sirin APIYASAWAT (Ramathibodi Hospital, Thailand)
Yongkeun CHO (Kyungpook National University Hospital, Republic of Korea)
Aya MIYAZAKI (National Cerebral and Cardiovascular Center, Japan)
Speaker
Genetics of QT Interval
Jyh-Ming Jimmy JUANG (National Taiwan University Hospital, Taiwan)
Risk Stratification in Congenital LQTS
Michael J. ACKERMAN (Mayo Clinic, United States)
Genetics and Clinical Aspects of Long-QT Syndrome
Takeshi AIBA (National Cerebral and Cardiovascular Center, Japan)
Genotype-Phenotype Correlation in Long QT Syndrome
Wataru SHIMIZU (Nippon Medical School, Japan)

SPAF
  
Anti 01: Stroke Prevention in AF-2016 12 October 13:30-15:00 RM 04
(GBR 103)
Chair
Chen-Chuan CHENG (Chi-Mei Medical Center, Taiwan)
Kee-Joon CHOI (ASAN Medical Center, Republic of Korea)
Ashish NABAR (KEM Hospital, India)
Speaker
Silent Cerebral Infarction and Anticoagulation in Catheter Ablation for Atrial Fibrillation
Toshiya KUROTOBI (Shiroyama Hospital, Japan)
New Risk Factors for Stroke in Atrial Fibrillation
Seil OH (Seoul National University Hospital, Republic of Korea)
Stroke Prevention in Elderly Atrial Fibrillation Patients: Drugs or Devices?
Win-Kuang SHEN (Mayo Clinic, United States)
Stroke Prevention for Taiwanese Patients with Atrial Fibrillation Using Modified CHA2DS2-VASc Score
Tze-Fan CHAO (Taipei Veterans General Hospital, Taiwan)

SPAF
  
Anti 02: Focus Session - Balance the Risk and Benefit of Anticoagulation for Stroke Prevention in AF 12 October 15:30-17:00 RM 04
(GBR 103)
Chair
David FOO (Tan Tock Seng Hospital, Singapore)
Nam-Ho KIM (Wonkwang University School of Medicine & Hospital, Republic of Korea)
Jiunn-Lee LIN (National Taiwan University Hospital, Taiwan)
Speaker
The Risks of Stroke and Bleeding Risks Scores in Patients with Atrial Fibrillation
Chern-En CHIANG (Taipei Veterans General Hospital, Taiwan)
Is Chronic Hemodialysis a Predictor of Periprocedural Bleeding Complications and Ischemic Stroke in Patients Undergoing Catheter Ablation of Atrial Fibrillation?: J-CARAF Study
Yuji MURAKAWA (Teikyo University School of Medicine, Japan)
Stroke Prevention in High Bleeding Risk Patients: Cancer and Intracranial Hemorrhage
Boyoung JOUNG (Severance Hospital, Republic of Korea)
Optimizing Stroke Prevention in Patients with AF and ACS
Seiji TAKATSUKI (Keio University Hospital, Japan)

Sponsor's Session
  
AF Symposium — Innovations in AF Management and Treatment supported by Medtronic 12 October 07:30-12:20 RM 04
(GBR 103)

Sponsor's Session
  
Hands-on Workshop supported by Biosense Webster 12 October 08:15-13:00 RM 08
(208)

Sponsor's Session
  
APHRS VR Proctorship Program supported by St. Jude Medical (Invited Only) 12 October 08:30-12:30 RM 11
(E 5)

Sponsor's Session
  
EP Growth Drivers supported by St. Jude Medical (Invited Only) 12 October 13:30-16:00 RM 11
(E 5)

Sponsor's Session
  
Scientific Evidence and Real Practice on Stroke Prevention of AF Patients with Anticoagulation supported by Daiichi Sankyo (By Invitation only) 12 October 14:00-18:00 RM 07
(203)

Sponsor's Session
  
Pre-Convention Meeting supported by St. Jude Medical (Invited Only) 12 October 16:00-18:00 RM 11
(E 5)